Willkommen, schön sind Sie da!
Logo Ex Libris

Atypical Antipsychotics in the Treatment of Schizophrenic Patients

  • Fester Einband
  • 352 Seiten
(0) Erste Bewertung abgeben
Alle Bewertungen ansehen
Dieter Naber has been the director of the Psychiatric University Hospital in Hamburg, Germany, since 1995. After studying medicine... Weiterlesen
88.00 CHF 70.40
Auslieferung erfolgt in der Regel innert 2 bis 3 Wochen.
Bestellung & Lieferung in eine Filiale möglich


Dieter Naber has been the director of the Psychiatric University Hospital in Hamburg, Germany, since 1995. After studying medicine in Göttingen and Bonn, Germany, Professor Naber worked at the Psychiatric Hospital of the University of Munich, Germany, from 1977 to 1995 as a ward doctor and then as a senior physician. In 1987, he gained a postdoctoral lecturing qualification with his lecture The etiological and therapeutic significance of endorphins in endogenous psychosis. Professor Naber conducted research during two periods at the National Institute of Mental Health, in 1978 1980 and again in 1984 1985. His current research concentrates on long-term neuroleptic treatment, efficacy and side effects of second-generation neuroleptics, and the subjective effects of neuroleptics. Martin Lambert is a professor of psychiatry at the University of Hamburg, where he is the head of the Psychosis Center, which includes the Psychosis Early Detection and Intervention Center (PEDIC). He performed his psychiatric training at the Department of Psychiatry and Psychotherapy at the University Medical Center in Hamburg, Germany. During his training, he spent 2 years at the Early Psychosis Prevention and Intervention Centre (EPPIC) in Melbourne, Australia. Professor Lambert's current research interests include the pharmacological and psychosocial treatment of schizophrenic, bipolar, and first-episode psychosis patients, and, especially, aspects of integrated care, remission and recovery, quality of life, and subjective wellbeing. Professor Lambert is the head of the network for a better mental health in Hamburg, which was founded by the German Research Association. He is the editor and author of several books about schizophrenia and has published various articles on schizophrenia and first-episode psychosis.

Almost a half century after the introduction of antipsychotics the treatment of schizophrenia has improved substantially. Nonetheless, the treating physician is still faced with large problems especially over long-term treatment. The main shortcomings of treatment with conventional or typical antipsychotics result, among other reasons, from the low compliance: The majority of schizophrenia patients discontinues the use of typical antipsychotics within a couple of months. Furthermore these medications have little or no effect on schizophrenic negative and affective symptoms. These shortcomings of treatment with typical antipsychotics may explain in part why, despite substantial advances in the acute treatment of patients, long-term prognosis for most schizophrenia patients has not seen comparable improvement over the last 10-30 years. All of the above-mentioned problems represent important arguments for the wider use of atypical antipsychotics. The fundamental idea for this edition was not only to present the theoretical background for the respective problem areas, but to develop guidelines for relevant clinical treatment issues and present them as clearly as possible. With the help of many tables and figures the clinician can receive a summary of the most important information for treatment and theoretical background. A special section of this book is dedicated to describing the different substances which are today categorized as atypical antipsychotics.


Titel: Atypical Antipsychotics in the Treatment of Schizophrenic Patients
EAN: 9783895995286
ISBN: 978-3-89599-528-6
Format: Fester Einband
Herausgeber: Uni-Med
Genre: Klinische Fächer
Anzahl Seiten: 352
Gewicht: 771g
Größe: H247mm x B177mm x T22mm
Jahr: 2002